Hiroshi Hosoda

Hiroshi Hosoda

Auto-generated profile, based on publicly available information

Hiroshi Hosoda

Translational Research Center, Kyoto University Hospital

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2003
Verified
Journal Article
Closed access
YSYoshito Shimizu
Yoshito Shimizu
NNNoritoshi Nagaya
Noritoshi Nagaya
TITakeshi Isobe
Takeshi Isobe
MIMichinori Imazu
Michinori Imazu
HOHiroyuki Okumura
Hiroyuki Okumura
NKNobuoki Kohno
Nobuoki Kohno


1 May 2009 in Expert Review of Endocrinology & Metabolism
Verified
Journal Article
Closed access
IKIchiro Kishimoto
Ichiro Kishimoto
TTTakeshi Tokudome
Takeshi Tokudome
DSDaryl O Schwenke
Daryl O Schwenke
STSoeki Takeshi
Soeki Takeshi
HHHiroshi Hosoda
Hiroshi Hosoda
KKKenji Kangawa
Kenji Kangawa
It has recently been revealed that ghrelin, a hormone discovered in the stomach, has a potential therapeutic role in the treatment of diseased hearts. In human patients with heart failure and in animal models, repeated subcutaneous administration of ghrelin improves cardiac dysfunction and remodeling. Moreover, ghrelin treatment early after myocardial infarction effectively reduces fatal arrhythmia and, consequently, mortality. The beneficial effects of ghrelin result from a growth hormone increase, an orexigenic effect, direct actions to the cardiovascular cells and its potent inhibitory action on sympathetic nervous activity, which is excessively activated in cardiac diseases. These results suggest that ghrelin could be a promising novel therapeutic agent for cardiac diseases.

1 October 2011 in Hepatogastroenterology
Verified
Journal Article
Closed access
KIKeisei Ikeda
Keisei Ikeda
Toshimi ChibaToshimi Chiba
Toshimi Chiba
TSTamotsu Sugai
Tamotsu Sugai
KKKenji Kangawa
Kenji Kangawa
HHHiroshi Hosoda
Hiroshi Hosoda
KSKazuyuki Suzuki
Kazuyuki Suzuki
The aim of this study was to clarify the relationship between plasma or mucosal ghrelin levels and endoscopic or histological severity, acid secretion and H. pylori infection associated with chronic gastritis. We measured plasma and mucosal ghrelin levels in 80 consecutive individuals with chronic gastritis, including 51 H. pylori-positive and 29 H. pylori-negative subjects. The topographic distribution of gastritis was divided into open type and closed type. During endoscopy, five adjacent biopsy specimens were obtained from the antrum, corpus and angulus. Using the updated Sydney System, histological parameters including activity, chronic inflammation, glandular atrophy and intestinal metaplasia were graded. Mucosal ghrelin, fasting plasma ghrelin, serum pepsinogen I and II, gastrin and H. pylori infection were all measured. All four measured histological parameters were significantly higher in H. pylori-positive patients than in H. pylori-negative patients. Serum pepsinogen I and II levels were also significantly higher in the H. pylori-positive group. Plasma and mucosal ghrelin levels correlated well with the topographic distribution of gastritis, and also with histological parameters of glandular atrophy in the corpus and angulus of the stomach. Plasma and mucosal ghrelin levels may reflect the extent of atrophy in the stomach irrespective of the presence of H. pylori infection, which is closely associated with the development of chronic gastritis.

1 September 2004
Verified
Journal Article
Closed access
HHHiroshi Hosoda
Hiroshi Hosoda
KKKenji Kangawa
Kenji Kangawa

31 December 2010 in Neuroscience Research
Verified
Journal Article
Closed access
MHMunetsugu Hara
Munetsugu Hara
YNYoshihiro Nishi
Yoshihiro Nishi
JYJunko Yoh
Junko Yoh
ISIkuhiko Shibuya
Ikuhiko Shibuya
TOTakashi Ohya
Takashi Ohya
TMToyojiro Matsuishi
Toyojiro Matsuishi